News
2d
GlobalData on MSNViroCell and AvenCell to advance allogeneic CAR-T therapy manufactureContract development and manufacturing organisation ViroCell Biologics has partnered AvenCell Therapeutics for expediting the development of new allogeneic chimeric antigen receptor (CAR)-T therapies ...
Today marks a turning point in global communication security. Sover, the world's first fully sovereign, end-to-end secure communication platform, is officially launching to the international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results